fig5
Figure 5. Suppression of MDA-MB-231 cell viability by DA and three dopamine receptor-1 (D1R)-selective agonists. SKF: SKF38393; A6: A68930; Fen: Fenoldopam. Cabergoline (Cab), a D2R agonist, has no effects. Redrawn and modified[2]
Cancer Drug Resistance
ISSN 2578-532X (Online)
Navigation
Navigation
Committee on Publication Ethics
https://members.publicationethics.org/members/cancer-drug-resistance
Portico
All published articles will preserved here permanently:
https://www.portico.org/publishers/oae/
